AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Knight, EL Bohn, RL Wang, PS Glynn, RJ Mogun, H Avorn, J
Citation: El. Knight et al., Predictors of uncontrolled hypertension in ambulatory patients, HYPERTENSIO, 38(4), 2001, pp. 809-814

Authors: Wang, PS Bohn, RL Glynn, RJ Mogun, H Avorn, J
Citation: Ps. Wang et al., Hazardous benzodiazepine regimens in the elderly: Effects of half-life, dosage, and duration on risk of hip fracture, AM J PSYCHI, 158(6), 2001, pp. 892-898

Authors: Bohn, RL
Citation: Rl. Bohn, The economics of bleeding disorders, HAEMOPHILIA, 6(5), 2000, pp. 491-493

Authors: Bohn, RL Gurwitz, JH Yeomans, SM Glynn, RJ Pasquale, LR Walker, AM Avorn, J
Citation: Rl. Bohn et al., Which patients are treated for glaucoma? An observational analysis, J GLAUCOMA, 9(1), 2000, pp. 38-44

Authors: Ganz, DA Glynn, RJ Mogun, H Knight, EL Bohn, RL Avorn, J
Citation: Da. Ganz et al., Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism, J GEN INT M, 15(11), 2000, pp. 776-781

Authors: Colowick, AB Bohn, RL Avorn, J Ewenstein, BM
Citation: Ab. Colowick et al., Immune tolerance induction in hemophilia patients with inhibitors: costly can be cheaper, BLOOD, 96(5), 2000, pp. 1698-1702

Authors: Bohn, RL Colowick, AB Avorn, J
Citation: Rl. Bohn et al., Probabilities, costs, and outcomes: methodological issues in modelling haemophilia treatment, HAEMOPHILIA, 5(6), 1999, pp. 374-377
Risultati: 1-7 |